Walgreens Boots Alliance, Inc. $WBA Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund lessened its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 27.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 96,464 shares of the pharmacy operator’s stock after selling 36,200 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Walgreens Boots Alliance were worth $1,078,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. First Trust Advisors LP acquired a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $368,000. Mirae Asset Global Investments Co. Ltd. increased its position in Walgreens Boots Alliance by 6.0% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 87,428 shares of the pharmacy operator’s stock worth $978,000 after purchasing an additional 4,926 shares during the last quarter. Concurrent Investment Advisors LLC increased its position in Walgreens Boots Alliance by 28.2% during the first quarter. Concurrent Investment Advisors LLC now owns 13,924 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 3,064 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in Walgreens Boots Alliance during the first quarter worth approximately $1,199,000. Finally, Allspring Global Investments Holdings LLC increased its position in Walgreens Boots Alliance by 3.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 42,332 shares of the pharmacy operator’s stock worth $472,000 after purchasing an additional 1,341 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on WBA. Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. UBS Group reissued a “neutral” rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Wall Street Zen began coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a “hold” rating for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $11.96 on Monday. The company has a market capitalization of $10.35 billion, a PE ratio of -1.64, a price-to-earnings-growth ratio of 1.41 and a beta of 0.80. The firm has a fifty day simple moving average of $11.56 and a 200-day simple moving average of $11.12. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.04. The business had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.63 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.